ANO1 and breast carcinoma: Similarly, Bristschgi et al. reported that 11q13 amplification resulted in a higher TMEM16A expression in human breast cancer than in non-11q13-amplified tumors, and TMEM16A gene amplification and protein overexpression correlated with poor prognosis [42].